CD38 and infection: Finally, it has to be considered that a profound depletion of long-lasting antibody producing plasma cells, either by anti-CD38 alone or, more importantly, in combination with other targeted therapies that affect memory cells, could also reduce the production of protective antibodies to previous infections, such as smallpox and measles [72], thereby exposing the recipients to an increased infectious risk.